LUCID NAMES NEW CEO, EXPANDS UBER DEAL

INDUSTRY DESK■ 1 MIN READ

TUE, APR 14, 2026

Lucid Motors has appointed a new CEO and expanded its robotaxi partnership with Uber, securing additional funding from the ride-hailing company and Saudi backers.

The luxury EV maker ended a year-long search for a chief executive following Peter Rawlinson's sudden departure. The new CEO comes from an unconventional background—elevator and escalator manufacturer Schindler—rather than the automotive industry. The appointment coincides with Lucid's expanded robotaxi agreement with Uber, which increases the number of vehicles the companies will deploy. The expanded deal includes fresh investment from both Uber and Saudi Arabia's Public Investment Fund, Lucid's primary financial backer. Lucid has faced significant challenges, including production delays and cash burn concerns. The new CEO and capital injection signal the company's push to diversify revenue through robotaxi services beyond traditional luxury EV sales. The Uber partnership represents a key revenue stream as Lucid works toward profitability.

■ MORE FROM THE STARTUPS DESK

P662RETRO RAISES $21M IN SERIES A FUNDING

Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.

4H AGO— Industry Desk

P663SWEDEN EMERGES AS EUROPE'S STARTUP POWERHOUSE

Sweden has built one of Europe's most vibrant startup ecosystems, drawing attention from investors and entrepreneurs across the continent. Cherry Ventures general partner Sophia Bendz breaks down the factors driving the Nordic nation's tech boom.

4H AGO— Industry Desk

P652METRIPORT RAISES $26M FOR PATIENT DATA TOOLS

Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.

7H AGO— AI Desk

P651FARO RAISES $37.3M TO ACCELERATE CLINICAL TRIALS

Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.

7H AGO— AI Desk

◄ BACK TO NEWS

LUCID NAMES NEW CEO, EXPANDS UBER DEAL

■ MORE FROM THE STARTUPS DESK

■ SUBSCRIBE TO THE DAILY BRIEF